Literature DB >> 18562141

Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant).

A Renieri1, F Mari, M A Mencarelli, E Scala, F Ariani, I Longo, I Meloni, G Cevenini, G Pini, G Hayek, M Zappella.   

Abstract

The preserved speech variant is the milder form of Rett syndrome: affected girls show the same stages of this condition and by the second half of the first decade are making slow progress in manual and verbal abilities. They walk without help, and may be able to make simple drawings and write a few words. Most of them can speak in sentences. Autistic behavior can often be observed. We previously described several cases in the pre-molecular era and subsequently reported a survey of 12 cases with MECP2 mutations. Seventeen new patients with the preserved speech variant and a proven MECP2 mutation have been clinically evaluated. Additional clinical data of our previously described cases are reported. These 29 preserved speech variant cases were compared with 129 classic Rett patients using a clinical severity score system including 22 different signs. There was both statistical and clinical evidence of the existence of this variant. On the basis of their abilities these girls can be distinguished as low-, intermediate- and high-functioning. Girls of the last two groups show a greater homogeneity: they speak in sentences, use their hands more easily, have normal somatic features, mild neurovegetative abnormalities, with autistic behavior in 76%, epilepsy in 30%, while girls of the first group are closer to classic Rett syndrome. The majority of patients carries either missense mutations (especially the p.R133C change) or late truncating mutations in the MECP2 gene. These results confirm the existence of this variant of Rett syndrome (Zappella variant), a clear example of progress of manual and verbal abilities, and not of a "preserved speech" and suggest corresponding diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562141     DOI: 10.1016/j.braindev.2008.04.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  35 in total

1.  Oxidative stress in Rett syndrome: natural history, genotype, and variants.

Authors:  Silvia Leoncini; Claudio De Felice; Cinzia Signorini; Alessandra Pecorelli; Thierry Durand; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  Variation in novel exons (RACEfrags) of the MECP2 gene in Rett syndrome patients and controls.

Authors:  Periklis Makrythanasis; Philipp Kapranov; Lucia Bartoloni; Alexandre Reymond; Samuel Deutsch; Roderic Guigó; France Denoeud; Jorg Drenkow; Colette Rossier; Francesca Ariani; Valeria Capra; Laurent Excoffier; Alessandra Renieri; Thomas R Gingeras; Stylianos E Antonarakis
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

3.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.

Authors:  Vishnu Anand Cuddapah; Rajesh B Pillai; Kiran V Shekar; Jane B Lane; Kathleen J Motil; Steven A Skinner; Daniel Charles Tarquinio; Daniel G Glaze; Gerald McGwin; Walter E Kaufmann; Alan K Percy; Jeffrey L Neul; Michelle L Olsen
Journal:  J Med Genet       Date:  2014-01-07       Impact factor: 6.318

4.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

5.  A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype.

Authors:  Abidemi A Adegbola; Michael L Gonzales; Andrew Chess; Janine M LaSalle; Gerald F Cox
Journal:  Hum Genet       Date:  2008-11-07       Impact factor: 4.132

6.  Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders.

Authors:  Elaine T Lim; Soumya Raychaudhuri; Stephan J Sanders; Christine Stevens; Aniko Sabo; Daniel G MacArthur; Benjamin M Neale; Andrew Kirby; Douglas M Ruderfer; Menachem Fromer; Monkol Lek; Li Liu; Jason Flannick; Stephan Ripke; Uma Nagaswamy; Donna Muzny; Jeffrey G Reid; Alicia Hawes; Irene Newsham; Yuanqing Wu; Lora Lewis; Huyen Dinh; Shannon Gross; Li-San Wang; Chiao-Feng Lin; Otto Valladares; Stacey B Gabriel; Mark dePristo; David M Altshuler; Shaun M Purcell; Matthew W State; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Richard A Gibbs; Gerard D Schellenberg; James S Sutcliffe; Bernie Devlin; Kathryn Roeder; Mark J Daly
Journal:  Neuron       Date:  2013-01-23       Impact factor: 17.173

7.  Developmental profile of speech-language and communicative functions in an individual with the preserved speech variant of Rett syndrome.

Authors:  Peter B Marschik; Ralf Vollmann; Katrin D Bartl-Pokorny; Vanessa A Green; Larah van der Meer; Thomas Wolin; Christa Einspieler
Journal:  Dev Neurorehabil       Date:  2013-07-19       Impact factor: 2.308

8.  Early socio-communicative forms and functions in typical Rett syndrome.

Authors:  Katrin D Bartl-Pokorny; Peter B Marschik; Jeff Sigafoos; Helen Tager-Flusberg; Walter E Kaufmann; Tobias Grossmann; Christa Einspieler
Journal:  Res Dev Disabil       Date:  2013-07-24

9.  InterRett, a model for international data collection in a rare genetic disorder.

Authors:  Sandra Louise; Sue Fyfe; Ami Bebbington; Nadia Bahi-Buisson; Alison Anderson; Mercé Pineda; Alan Percy; Bruria Ben Zeev; Xi Ru Wu; Xinhua Bao; Patrick Mac Leod; Judith Armstrong; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2009-07

10.  Early Vocal Development in Autism Spectrum Disorder, Rett Syndrome, and Fragile X Syndrome: Insights from Studies using Retrospective Video Analysis.

Authors:  Laura Roche; Dajie Zhang; Katrin D Bartl-Pokorny; Florian B Pokorny; Björn W Schuller; Gianluca Esposito; Sven Bölte; Herbert Roeyers; Luise Poustka; Markus Gugatschka; Hannah Waddington; Ralf Vollmann; Christa Einspieler; Peter B Marschik
Journal:  Adv Neurodev Disord       Date:  2018-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.